Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression.
about
Personality as an intermediate phenotype for genetic dissection of alcohol use disorder.Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease.Monoamine Oxidase Is Overactivated in Left and Right Ventricles from Ischemic Hearts: An Intriguing Therapeutic Target.Type B and A monoamine oxidase and their inhibitors regulate the gene expression of Bcl-2 and neurotrophic factors in human glioblastoma U118MG cells: different signal pathways for neuroprotection by selegiline and rasagiline.Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.Multitarget strategies in Alzheimer's disease: benefits and challenges on the road to therapeutics.Use of monoamine oxidase inhibitors in chronic neurodegeneration.Aberrant CpG Methylation Mediates Abnormal Transcription of MAO-A Induced by Acute and Chronic L-3,4-Dihydroxyphenylalanine Administration in SH-SY5Y Neuronal Cells.Type A and B monoamine oxidases distinctly modulate signal transduction pathway and gene expression to regulate brain function and survival of neurons.Impaired Dopamine-Dependent Locomotory Behavior of C. elegans Neuroligin Mutants Depends on the Catechol-O-Methyltransferase COMT-4.Association of Monoamine Oxidase A (MAOA) Gene uVNTR and rs6323 Polymorphisms with Attention Deficit and Hyperactivity Disorder in Korean ChildrenSculpting Cerebral Cortex with Serotonin in Rodent and PrimateALSUntangled 40: Ayahuasca
P2860
Q36239985-2F63EFB7-748B-4B59-BB48-CC105C1A526BQ37005143-4E2F844A-8A1B-4E03-8E98-96FADD93CFF7Q37504039-AF7907DC-7C03-43CA-B571-3105E05A6686Q38701423-EE0A47AF-66A7-4177-8BA8-6B9F1D5F681DQ38834545-A571B53A-4A37-4F12-9F66-8B02083E2904Q38881147-12B1C140-4D78-4FD4-9915-6E7AF3EB2A14Q39044780-27D6D5D1-034C-48AB-96E3-46ED969901F2Q39096105-7CEDEBC7-E579-4AE0-9233-2DE38F5F44A1Q47668415-C96E810A-552B-4580-A32E-218F4C8EFA83Q47844420-EA86E049-E69F-4E1D-B807-4D10E09770C4Q57825527-7C9B1FEE-5142-4D34-91FD-9E42E77FDE5AQ57834789-BD8D8BC7-172C-4E81-A94D-FEDDC0E49D9EQ58125512-8F21C188-AF11-4A2B-8385-B188E7EF1CAA
P2860
Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Modulation of monoamine oxidas ...... lved in type A MAO expression.
@en
type
label
Modulation of monoamine oxidas ...... lved in type A MAO expression.
@en
prefLabel
Modulation of monoamine oxidas ...... lved in type A MAO expression.
@en
P2093
P2860
P1476
Modulation of monoamine oxidas ...... lved in type A MAO expression.
@en
P2093
Makoto Naoi
Peter Riederer
Wakako Maruyama
P2860
P2888
P304
P356
10.1007/S00702-014-1362-4
P577
2015-01-22T00:00:00Z